Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
10.91
+0.39 (3.71%)
May 21, 2026, 4:00 PM EDT - Market closed
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $521.15 million as of May 22, 2026. Its market cap has increased by 537.37% in one year.
Market Cap
521.15M
Enterprise Value
375.33M
1-Year Change
537.37%
Ranking
Category
Stock Price
$10.91
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has increased from $403.20M to $521.15M, an increase of 29.26%. That is a compound annual growth rate of 5.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 521.15M | 172.89% |
| Dec 31, 2025 | 190.98M | 57.83% |
| Dec 31, 2024 | 121.00M | 62.54% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
| Aug 10, 2021 | 403.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 480.79M |
| Contineum Therapeutics | 477.05M |
| Prothena Corporation | 474.84M |
| Immix Biopharma | 469.69M |
| ProKidney | 468.04M |
| Achieve Life Sciences | 456.83M |
| vTv Therapeutics | 452.82M |
| Ocugen | 440.08M |